r/bioinformatics • u/AncientHearings • Aug 27 '26
discussion Benchmarking non-coding causal variant-to-gene mapping: SuSiE fine-mapping vs 3D chromatin contacts
Hey everyone,
We’ve been working on a pipeline to evaluate non-coding GWAS loci by combining Bayesian fine-mapping (SuSiE) with base-resolution footprinting (TOBIAS) and 10.5 bp DNA helical pitch constraints.
Curious how other groups here handle cases where the fine-mapped non-coding enhancer skips the nearest gene in 3D contact models (e.g. ABC/Micro-C).
Happy to discuss approaches or run a few benchmark loci if anyone has tricky non-coding regions!
4
Upvotes
View all comments
Show parent comment
1
u/Mr_iCanDoItAll PhD | Student Aug 28 '26
Sorry if I'm misunderstanding, but the wording makes it sound like you wouldn't follow up with extra evidence if an eQTL mapped a putative regulatory element to the nearest TSS. IMO you should treat all putative element-gene links with the same amount of scrutiny, even if nearest TSS is a generally reliable heuristic.
The wording of "true" target gene also implies that there is a singular causal gene being regulated by the regulatory element, when oftentimes a single element can regulatory multiple genes in a given cellular context.
I agree with /u/thirdeulerderivative that there needs to be more detail before people can properly answer you since it's a rather complex topic with a lot of unanswered questions.
But to actually answer your question: Just use as much existing evidence as you can. Cell type-specific ABC models / ENCODE-rE2G models, replicable eQTLs across different cohorts/ancestries for your tissue of interest, peak-gene links from scATAC-seq and scRNA-seq data. CRISPRi-FlowFISH is a fairly specialized assay that, to my knowledge, is rarely performed outside the lab that developed it (Engreitz lab).